Survival benefits of different immunotherapies for hepatocellular carcinoma: a meta-analysis highlighting age, gender, etiology, and tumor burden

Ming‐Cheng Guan(Jiangnan University), Hong Zhu(Soochow University), Hao Li(Uppsala University Hospital), Mei Yang(Tongji University), Sun D, Lei Hong(Suzhou Municipal Hospital), Qian Ding(Soochow University), Na Li(Soochow University)
Frontiers in Immunology
December 10, 2025
10.3389/fimmu.2025.1713151
Cited by 2

Related Papers

Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells
|Molecular Cancer|2011|700
MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor
|Clinical Cancer Research|2009|435
MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1
|Oncogene|2011|248
Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis
|Clinical Rheumatology|2010|230
Explicit hypoxia targeting with tumor suppression by creating an “obligate” anaerobic Salmonella Typhimurium strain
|Scientific Reports|2012|179